Jane Street’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $130M | Buy |
2,148,500
+572,600
| +36% | +$33.4M | 0.02% | 534 |
|
|
2025
Q4 | $85M | Sell |
1,575,900
-850,700
| -35% | -$40.9M | 0.01% | 662 |
|
|
2025
Q3 | $109M | Buy |
2,426,600
+689,700
| +40% | +$32.2M | 0.02% | 553 |
|
|
2025
Q2 | $80.4M | Sell |
1,736,900
-2,316,100
| -57% | -$114M | 0.02% | 547 |
|
|
2025
Q1 | $247M | Buy |
4,053,000
+347,100
| +9% | +$20.2M | 0.06% | 183 |
|
|
2024
Q4 | $210M | Buy |
3,705,900
+91,000
| +3% | +$5.08M | 0.05% | 239 |
|
|
2024
Q3 | $187M | Sell |
3,614,900
-265,800
| -7% | -$12.5M | 0.04% | 246 |
|
|
2024
Q2 | $161M | Buy |
3,880,700
+3,096,800
| +395% | +$139M | 0.04% | 255 |
|
|
2024
Q1 | $42.5M | Sell |
783,900
-904,900
| -54% | -$46.1M | 0.01% | 717 |
|
|
2023
Q4 | $86.7M | Sell |
1,688,800
-8,198,100
| -83% | -$430M | 0.02% | 440 |
|
|
2023
Q3 | $574M | Buy |
9,886,900
+7,732,900
| +359% | +$474M | 0.19% | 52 |
|
|
2023
Q2 | $138M | Sell |
2,154,000
-22,200
| -1% | -$1.49M | 0.05% | 243 |
|
|
2023
Q1 | $151M | Buy |
2,176,200
+840,600
| +63% | +$59.3M | 0.06% | 193 |
|
|
2022
Q4 | $96.1M | Sell |
1,335,600
-1,136,600
| -46% | -$85.7M | 0.04% | 304 |
|
|
2022
Q3 | $176M | Sell |
2,472,200
-2,559,200
| -51% | -$186M | 0.08% | 151 |
|
|
2022
Q2 | $387M | Buy |
5,031,400
+2,783,100
| +124% | +$212M | 0.16% | 63 |
|
|
2022
Q1 | $164M | Sell |
2,248,300
-358,400
| -14% | -$24.1M | 0.05% | 228 |
|
|
2021
Q4 | $163M | Sell |
2,606,700
-929,100
| -26% | -$54.5M | 0.05% | 232 |
|
|
2021
Q3 | $209M | Buy |
3,535,800
+297,400
| +9% | +$19.6M | 0.07% | 156 |
|
|
2021
Q2 | $216M | Buy |
3,238,400
+1,648,900
| +104% | +$108M | 0.08% | 152 |
|
|
2021
Q1 | $100M | Sell |
1,589,500
-77,400
| -5% | -$4.82M | 0.05% | 267 |
|
|
2020
Q4 | $103M | Sell |
1,666,900
-149,500
| -8% | -$9.19M | 0.05% | 239 |
|
|
2020
Q3 | $110M | Buy |
1,816,400
+751,100
| +71% | +$45.2M | 0.07% | 200 |
|
|
2020
Q2 | $62.6M | Buy |
1,065,300
+225,400
| +27% | +$13.5M | 0.05% | 281 |
|
|
2020
Q1 | $46.8M | Buy |
839,900
+612,500
| +269% | +$37.4M | 0.05% | 255 |
|
|
2019
Q4 | $14.6M | Sell |
227,400
-429,200
| -65% | -$24.6M | 0.02% | 492 |
|
|
2019
Q3 | $33.3M | Buy |
656,600
+163,200
| +33% | +$7.67M | 0.06% | 238 |
|
|
2019
Q2 | $22.4M | Sell |
493,400
-414,500
| -46% | -$19.3M | 0.04% | 344 |
|
|
2019
Q1 | $43.3M | Buy |
907,900
+670,200
| +282% | +$33.4M | 0.07% | 205 |
|
|
2018
Q4 | $12.4M | Buy |
237,700
+150,900
| +174% | +$8.11M | 0.03% | 473 |
|
|
2018
Q3 | $5.39M | Sell |
86,800
-47,400
| -35% | -$2.81M | 0.01% | 984 |
|
|
2018
Q2 | $7.43M | Buy |
134,200
+84,100
| +168% | +$4.54M | 0.02% | 778 |
|
|
2018
Q1 | $3.17M | Buy |
50,100
+12,100
| +32% | +$778K | 0.01% | 1364 |
|
|
2017
Q4 | $2.33M | Sell |
38,000
-18,200
| -32% | -$1.14M | 0.01% | 1452 |
|
|
2017
Q3 | $3.58M | Sell |
56,200
-33,700
| -37% | -$1.97M | 0.01% | 1115 |
|
|
2017
Q2 | $5.01M | Buy |
89,900
+69,300
| +336% | +$3.77M | 0.02% | 775 |
|
|
2017
Q1 | $1.12M | Sell |
20,600
-55,200
| -73% | -$3.03M | 0.01% | 1944 |
|
|
2016
Q4 | $4.43M | Sell |
75,800
-16,900
| -18% | -$924K | 0.02% | 750 |
|
|
2016
Q3 | $5M | Buy |
92,700
+27,300
| +42% | +$1.75M | 0.02% | 591 |
|
|
2016
Q2 | $4.81M | Sell |
65,400
-38,400
| -37% | -$2.71M | 0.02% | 650 |
|
|
2016
Q1 | $6.63M | Buy |
103,800
+41,400
| +66% | +$2.61M | 0.04% | 441 |
|
|
2015
Q4 | $4.29M | Buy |
62,400
+13,000
| +26% | +$859K | 0.03% | 577 |
|
|
2015
Q3 | $2.92M | Buy |
49,400
+34,900
| +241% | +$2.21M | 0.02% | 720 |
|
|
2015
Q2 | $965K | Sell |
14,500
-6,100
| -30% | -$402K | 0.01% | 1595 |
|
|
2015
Q1 | $1.33M | Buy |
+20,600
| New | +$1.29M | 0.01% | 1148 |
|
Other funds holding BMY
VCM
VPM
Jane Street's BMY Position: Q1 2026 in Review
Jane Street increased its Bristol-Myers Squibb (BMY) stake by 1,287% in Q1 2026, buying an estimated $123M and bringing the position to 2,265,508 shares worth $137M. The position accounts for 0.02% of the portfolio, ranked #518.
Jane Street first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $234M in Q4 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Jane Street held 2,265,508 shares of Bristol-Myers Squibb worth $137M as of Q1 2026.
- Jane Street bought 2,102,131 Bristol-Myers Squibb shares in Q1 2026, an estimated $123M.
- Bristol-Myers Squibb made up 0.02% of Jane Street's portfolio in Q1 2026, its #518 holding.
- Jane Street first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- Jane Street's Bristol-Myers Squibb position peaked at $234M in Q4 2023.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.